10-Q: Charlotte's Web Holdings Reports Q3 2024 Results with Revenue Decline but Cost Cutting Measures

Charlotte's Web Holdings experienced a revenue decrease in Q3 2024 compared to the previous year, but implemented cost-cutting measures and saw some growth in its gummy product line.

Summary

• Charlotte's Web Holdings reported a revenue of $12.587 million for the third quarter of 2024, a decrease of 11.9% compared to the same period in 2023.
• Direct-to-consumer revenue decreased by 13.4% year-over-year, while business-to-business revenue declined by 10.7%.
• The company's gross profit margin decreased to 53.0% in Q3 2024, down from 55.5% in Q3 2023.
• Operating loss for the quarter was $6.020 million, compared to $11.960 million in the same quarter of the previous year.
• The company's net loss for the quarter was $5.787 million, or $0.04 per share, compared to a net loss of $15.143 million, or $0.10 per share, in Q3 2023.
• For the nine months ended September 30, 2024, total revenue was $37 million, a decrease of 21.8% compared to the same period in 2023.
• The company's net loss for the nine months ended September 30, 2024 was $26.478 million, or $0.17 per share, compared to a net loss of $15.211 million, or $0.10 per share, in the same period of 2023.
• The company has taken cost-cutting measures to align with current revenue levels, which are expected to result in significantly lower selling, general, and administrative expenses compared to 2023.
• The company's cash and cash equivalents were $24.620 million as of September 30, 2024, down from $47.820 million at the end of 2023.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with declining revenue and gross profit, but also cost-cutting measures and new product launches. The overall sentiment is slightly negative due to the financial losses and challenges, but there are some positive developments that could improve the company's future performance.

Positives

• The company's operating loss improved in Q3 2024 compared to the same period in 2023.
• The company implemented cost-cutting measures to align with current revenue levels.
• The company launched a new CBN sleep gummy, expanding its product line beyond CBD.
• The company reduced prices on its CBD oils, improving consumer accessibility.
• The company added Walmart as a retail partner, expanding its distribution network.
• The company saw continued sales growth in its gummy product line.
• The company transitioned to a new e-commerce platform with improved software integrations.

Negatives

• Total revenue decreased by 11.9% in Q3 2024 compared to Q3 2023.
• Direct-to-consumer and business-to-business revenue both experienced declines.
• Gross profit margin decreased to 53.0% in Q3 2024, down from 55.5% in Q3 2023.
• The company's net loss for the quarter was $5.787 million.
• The company's cash and cash equivalents decreased to $24.620 million as of September 30, 2024.
• The company experienced a $3.7 million increase in inventory provisions during the three months ended June 30, 2024.

Risks

• The company's ability to fund its operations depends on future operating performance and cost management.
• The company's ability to raise additional funds is dependent on market conditions and investor sentiment.
• New state regulations may impact the company's ability to sell certain products as currently formulated or packaged.
• The company faces risks related to the hemp industry and market perceptions.
• The company's financial performance is subject to general economic conditions and industry regulatory changes.

Future Outlook

The company expects selling, general, and administrative expenses to be significantly lower compared to 2023 due to cost reduction actions. The company plans to meet its liquidity requirements for at least the next twelve months through cash on hand and operations. The company may consider expanding its product line beyond hemp-based products if the science and the company's founding principles support such expansion.

Management Comments

• Charlotte's Web has refreshed its mission to 'Unearth the Science of Nature to Revolutionize Wellness,' and is evolving its wellness offerings both to strengthen our core leadership in CBD, and extend beyond CBD to include a broader range of botanical wellness solutions, including minor cannabinoids.
• The company believes expanding beyond CBD leverages the company's brand recognition, intellectual property, and partnerships.
• The company made additional cost cutting measures in the third quarter to further align with current revenue levels.

Industry Context

The company is operating in a rapidly evolving botanical wellness products industry and is working to capitalize on this by driving customer acquisition and retention, as well as accelerating retail expansion. The company is also navigating new state regulations that impact the sale of certain products.

Comparison to Industry Standards

• The company's revenue decline is consistent with the challenges faced by other CBD companies in a competitive market.
• The company's gross margin of 53.0% in Q3 2024 is lower than some industry benchmarks, indicating potential pricing or cost pressures.
• The company's operating loss of $6.020 million in Q3 2024 is an improvement compared to the previous year, but still reflects the challenges of achieving profitability in the current market.
• The company's cash position of $24.620 million as of September 30, 2024, is lower than some competitors, indicating a need for careful cash management.
• The company's expansion into CBN and other botanical products is a strategy similar to other companies in the wellness space looking to diversify their offerings.

Related Party Transactions

• The company extended a secured promissory note with one of its founders to November 13, 2029.
• The company has a purchase option with Stanley Brothers USA, where certain founders are majority shareholders.
• The company has a joint venture with DeFloria, where a co-founder of Charlotte's Web is a partial owner.
• The company has a master services agreement with DeFloria, recognizing $74 and $459 in revenue and cost of goods sold for the three and nine months ended September 30, 2024, respectively.
• The company has a consulting agreement with Jared Stanley, a co-founder and board member, for a bi-weekly fee of $6.

Stakeholder Impact

• Shareholders may be concerned about the revenue decline and net losses.
• Employees may be affected by cost-cutting measures.
• Customers may benefit from the price reductions on CBD oils and new product launches.
• Suppliers may be impacted by changes in the company's production and sourcing strategies.
• Creditors may be concerned about the company's liquidity and ability to repay debts.

Next Steps

• The company will continue to assess the business and financial impacts of new state regulations.
• The company will continue to invest in R&D efforts to identify new product opportunities.
• The company will work to capitalize on the rapidly emerging botanical wellness products industry by driving customer acquisition and retention, as well as accelerating retail expansion.
• The company may consider expanding its product line beyond hemp-based products should the science and the company's founding principles support such expansion.

Key Dates

Keywords

CBD, hemp, cannabinoids, revenue, gross profit, operating loss, net loss, e-commerce, retail, cost cutting, CBN, gummies, financial results, Charlotte's Web